{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:01:47Z","timestamp":1789599707815,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.theisn.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.kint.2017.03.031","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T08:45:21Z","timestamp":1495529121000},"page":"922-933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Anticystogenic activity of a small molecule PAK4 inhibitor may be a novel treatment for autosomal dominant polycystic kidney disease"],"prefix":"10.1016","volume":"92","author":[{"given":"Vicki J.","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Trott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omran","family":"Abu Aboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyuhwan","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai Kuan","family":"Dionne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth J.","family":"Chmiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Senapedis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkan","family":"Baloglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moe R.","family":"Mahjoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaogang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2017.03.031_bib1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1056\/NEJM199307293290508","article-title":"Autosomal dominant polycystic kidney disease","volume":"329","author":"Gabow","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2017.03.031_bib2","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2017.03.031_bib3","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/ki.1992.195","article-title":"Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease","volume":"41","author":"Gabow","year":"1992","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.03.031_bib4","doi-asserted-by":"crossref","first-page":"F492","DOI":"10.1152\/ajprenal.00238.2015","article-title":"The cpk model of recessive PKD shows glutamine dependence associated with the production of the oncometabolite 2-hydroxyglutarate","volume":"309","author":"Hwang","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2017.03.031_bib5","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.3092","article-title":"Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy","volume":"19","author":"Rowe","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2017.03.031_bib6","doi-asserted-by":"crossref","first-page":"e0146654","DOI":"10.1371\/journal.pone.0146654","article-title":"Inhibition of aerobic glycolysis attenuates disease progression in polycystic kidney disease","volume":"11","author":"Riwanto","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2017.03.031_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pharmthera.2015.02.004","article-title":"Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer","volume":"151","author":"Sampath","year":"2015","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.kint.2017.03.031_bib8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejcb.2013.03.002","article-title":"P21-activated kinase 4\u2014not just one of the PAK","volume":"92","author":"Dart","year":"2013","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.kint.2017.03.031_bib9","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1158\/1535-7163.MCT-16-0197","article-title":"Dual and specific inhibition of NAMPT and PAK4 by KPT-9274 decreases kidney cancer growth","volume":"15","author":"Abu Aboud","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.kint.2017.03.031_bib10","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/jcb.23092","article-title":"PAK4 is required for regulation of the cell-cycle regulatory protein p21, and for control of cell-cycle progression","volume":"112","author":"Nekrasova","year":"2011","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.kint.2017.03.031_bib11","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1093\/emboj\/17.22.6527","article-title":"PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia","volume":"17","author":"Abo","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.kint.2017.03.031_bib12","doi-asserted-by":"crossref","first-page":"7122","DOI":"10.1128\/MCB.23.20.7122-7133.2003","article-title":"PAK4 kinase is essential for embryonic viability and for proper neuronal development","volume":"23","author":"Qu","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.kint.2017.03.031_bib13","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1158\/1541-7786.MCR-08-0087","article-title":"The pak4 protein kinase plays a key role in cell survival and tumorigenesis in athymic mice","volume":"6","author":"Liu","year":"2008","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.kint.2017.03.031_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/1871520615666150617111414","article-title":"Therapeutic potential of targeting PAK signaling","volume":"16","author":"Senapedis","year":"2015","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.kint.2017.03.031_bib15","doi-asserted-by":"crossref","unstructured":"Jiang YY, Lin DC, Mayakonda A, et\u00a0al. Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma [e-pub ahead of print]. Gut. http:\/\/dx.doi.org\/10.1136\/gutjnl-2016-311818.","DOI":"10.1136\/gutjnl-2016-311818"},{"key":"10.1016\/j.kint.2017.03.031_bib16","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1182\/blood-2016-06-724831","article-title":"Functional role and therapeutic targeting of p21-associated kinase 4 in multiple myeloma","volume":"129","author":"Fulciniti","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.kint.2017.03.031_bib17","doi-asserted-by":"crossref","first-page":"42555","DOI":"10.1038\/srep42555","article-title":"A\u00a0novel orally bioavailable compound KPT-9274 inhibits PAK4, and blocks triple negative breast cancer tumor growth","volume":"7","author":"Rane C SW","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2017.03.031_bib18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1158\/1535-7163.MCT-16-0205","article-title":"Novel p21-activated kinase 4 (PAK4) allosteric modulators overcome drug resistance and stemness in pancreatic ductal adenocarcinoma","volume":"16","author":"Aboukameel","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.kint.2017.03.031_bib19","doi-asserted-by":"crossref","first-page":"R763","DOI":"10.1152\/ajpregu.2000.278.3.R763","article-title":"Apoptosis in polycystic kidney disease: involvement of caspases","volume":"278","author":"Ali","year":"2000","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.kint.2017.03.031_bib20","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1074\/jbc.274.8.4947","article-title":"The polycystic kidney disease 1 gene product modulates Wnt signaling","volume":"274","author":"Kim","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2017.03.031_bib21","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1038\/sj.onc.1204825","article-title":"Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the beta-catenin gene","volume":"20","author":"Saadi-Kheddouci","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.kint.2017.03.031_bib22","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1074\/jbc.M410697200","article-title":"Cystic renal neoplasia following conditional inactivation of apc in mouse renal tubular epithelium","volume":"280","author":"Qian","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2017.03.031_bib23","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/ng1552","article-title":"Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways","volume":"37","author":"Simons","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2017.03.031_bib24","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00018-012-1052-z","article-title":"The role of the cilium in normal and abnormal cell cycles: emphasis on renal cystic pathologies","volume":"70","author":"Pan","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.kint.2017.03.031_bib25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.bbamcr.2011.11.013","article-title":"Nucleo-cytoplasmic shuttling of PAK4 modulates \u03b2-catenin intracellular translocation and signaling","volume":"1823","author":"Li","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.kint.2017.03.031_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ki.2011.87","article-title":"WNT\/beta-catenin signaling in polycystic kidney disease","volume":"80","author":"Wuebken","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.03.031_bib27","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.cell.2011.04.019","article-title":"Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways","volume":"145","author":"Sang","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.kint.2017.03.031_bib28","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.cub.2012.06.057","article-title":"Supernumerary centrosomes nucleate extra cilia and compromise primary cilium signaling","volume":"22","author":"Mahjoub","year":"2012","journal-title":"Curr Biol"},{"key":"10.1016\/j.kint.2017.03.031_bib29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1242\/jcs.1993.Supplement_17.30","article-title":"Epithelial polarity and differentiation in polycystic kidney disease","volume":"17","author":"Avner","year":"1993","journal-title":"J\u00a0Cell Sci Suppl"},{"key":"10.1016\/j.kint.2017.03.031_bib30","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1681\/ASN.2006030295","article-title":"Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator\/Na(+),K(+),2Cl(-) Co-transporter-dependent cystic dilation","volume":"17","author":"Magenheimer","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.03.031_bib31","doi-asserted-by":"crossref","first-page":"e57797","DOI":"10.1371\/journal.pone.0057797","article-title":"Ex\u00a0vivo modeling of chemical synergy in prenatal kidney cystogenesis","volume":"8","author":"Anders","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2017.03.031_bib32","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1158\/0008-5472.CAN-14-1703","article-title":"Grade-dependent metabolic reprogramming in kidney cancer revealed by combined proteomics and metabolomics analysis","volume":"75","author":"Wettersten","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.kint.2017.03.031_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/138161209787185823","article-title":"Niacin status, NAD distribution and ADP-ribose metabolism","volume":"15","author":"Kirkland","year":"2009","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.kint.2017.03.031_bib34","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1128\/MCB.00112-09","article-title":"The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors","volume":"29","author":"Watson","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.kint.2017.03.031_bib35","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0272-6386(12)80507-5","article-title":"Polycystic kidney disease: neoplasia in disguise","volume":"15","author":"Grantham","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2017.03.031_bib36","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrneph.2015.46","article-title":"The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease","volume":"11","author":"Seeger-Nukpezah","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2017.03.031_bib37","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1097\/01.ASN.0000141055.57643.E0","article-title":"Intraflagellar transport and cilia-dependent renal disease: the ciliary hypothesis of polycystic kidney disease","volume":"15","author":"Pazour","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.03.031_bib38","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/emboj\/18.2.297","article-title":"The structure of a PKD domain from polycystin-1: implications for polycystic kidney disease","volume":"18","author":"Bycroft","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.kint.2017.03.031_bib39","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.272.5266.1339","article-title":"PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein","volume":"272","author":"Mochizuki","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.kint.2017.03.031_bib40","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/hmg\/ddn039","article-title":"Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1","volume":"17","author":"Shibazaki","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.kint.2017.03.031_bib41","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1172\/JCI64401","article-title":"Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease","volume":"123","author":"Zhou","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2017.03.031_bib42","doi-asserted-by":"crossref","first-page":"827","DOI":"10.4161\/cbt.12.9.17680","article-title":"Sorafenib attenuates p21 in kidney cancer cells and augments cell death in combination with DNA-damaging chemotherapy","volume":"12","author":"Inoue","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.kint.2017.03.031_bib43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1023\/A:1009774914564","article-title":"Use of a 96-well plate reader to evaluate proliferation of equine satellite cell clones in\u00a0vitro","volume":"19","author":"Byrne KM","year":"1998","journal-title":"Methods Cell Sci"},{"key":"10.1016\/j.kint.2017.03.031_bib44","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1093\/hmg\/ddv136","article-title":"Therapeutic targeting of BET bromodomain protein, Brd4, delays cyst growth in ADPKD","volume":"24","author":"Zhou","year":"2015","journal-title":"Hum Mol Genet"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381730234X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381730234X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T19:48:23Z","timestamp":1569354503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S008525381730234X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S008525381730234X"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2017.03.031","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticystogenic activity of a small molecule PAK4 inhibitor may be a novel treatment for autosomal dominant polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2017.03.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier, Inc., on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}]}}